Brokerages Set Pacific Biosciences of California, Inc. (NASDAQ:PACB) PT at $2.79
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the stock, Marketbeat reports. Six analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12-month target price […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the stock, Marketbeat reports. Six analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12-month target price […]
